Catalyst Wire Dossier Catalyst Wire Dossier

RAI Plus Immunotherapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RAI Plus Immunotherapy, covering 2024-03-22 to 2024-03-22. Get the full timeline:

Most recent: Clinical Trial Update: RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers [EARLY_Phase 1]

See pricing